Guardian Capital (Canada)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.6M | Buy |
177,185
+6,933
| +4% | +$1.3M | 0.82% | 36 |
|
|
2026
Q1 | $33.6M | Buy |
170,252
+137,515
| +420% | +$26.5M | 0.89% | 35 |
|
|
2025
Q4 | $6.02M | Sell |
32,737
-8,800
| -21% | -$1.54M | 0.18% | 76 |
|
|
2025
Q3 | $6.37M | Buy |
41,537
+9,824
| +31% | +$1.49M | 0.21% | 76 |
|
|
2025
Q2 | $4.43M | Buy |
31,713
+2,748
| +9% | +$385K | 0.16% | 82 |
|
|
2025
Q1 | $4.26M | Sell |
28,965
-511
| -2% | -$73.9K | 0.17% | 83 |
|
|
2024
Q4 | $3.86M | Buy |
29,476
+2,249
| +8% | +$315K | 0.14% | 85 |
|
|
2024
Q3 | $4.24M | Sell |
27,227
-763
| -3% | -$123K | 0.16% | 79 |
|
|
2024
Q2 | $4.37M | Buy |
27,990
+1,853
| +7% | +$279K | 0.16% | 77 |
|
|
2024
Q1 | $3.54M | Buy |
26,137
+2,492
| +11% | +$330K | 0.12% | 82 |
|
|
2023
Q4 | $3.18M | Sell |
23,645
-2,415
| -9% | -$314K | 0.11% | 83 |
|
|
2023
Q3 | $3.53M | Sell |
26,060
-867
| -3% | -$118K | 0.13% | 84 |
|
|
2023
Q2 | $3.85M | Sell |
26,927
-628
| -2% | -$92.4K | 0.12% | 82 |
|
|
2023
Q1 | $3.83M | Sell |
27,555
-1,266
| -4% | -$170K | 0.12% | 86 |
|
|
2022
Q4 | $3.91M | Sell |
28,821
-664
| -2% | -$83.3K | 0.13% | 86 |
|
|
2022
Q3 | $3.23M | Buy |
29,485
+1,677
| +6% | +$213K | 0.11% | 88 |
|
|
2022
Q2 | $3.67M | Buy |
27,808
+9,737
| +54% | +$1.28M | 0.11% | 91 |
|
|
2022
Q1 | $2.4M | Buy |
18,071
+146
| +0.8% | +$17.5K | 0.05% | 103 |
|
|
2021
Q4 | $2.09M | Sell |
17,925
-1,775
| -9% | -$209K | 0.04% | 111 |
|
|
2021
Q3 | $2.37M | Sell |
19,700
-411
| -2% | -$47.8K | 0.05% | 106 |
|
|
2021
Q2 | $2.41M | Buy |
20,111
+169
| +0.8% | +$18.5K | 0.05% | 106 |
|
|
2021
Q1 | $1.98M | Sell |
19,942
-8,376
| -30% | -$842K | 0.03% | 112 |
|
|
2020
Q4 | $2.83M | Sell |
28,318
-35
| -0.1% | -$3.71K | 0.07% | 87 |
|
|
2020
Q3 | $3.11M | Buy |
28,353
+66
| +0.2% | +$7.34K | 0.08% | 82 |
|
|
2020
Q2 | $2.99M | Sell |
28,287
-170
| -0.6% | -$17.6K | 0.08% | 77 |
|
|
2020
Q1 | $2.54M | Buy |
28,457
+11,069
| +64% | +$1.04M | 0.08% | 74 |
|
|
2019
Q4 | $1.73M | Sell |
17,388
-27,010
| -61% | -$2.54M | 0.04% | 86 |
|
|
2019
Q3 | $3.96M | Buy |
44,398
+9,013
| +25% | +$781K | 0.08% | 77 |
|
|
2019
Q2 | $2.92M | Buy |
35,385
+1,969
| +6% | +$154K | 0.06% | 85 |
|
|
2019
Q1 | $2.7M | Sell |
33,416
-30,576
| -48% | -$2.41M | 0.05% | 88 |
|
|
2018
Q4 | $4.86M | Sell |
63,992
-6,741
| -10% | -$526K | 0.1% | 85 |
|
|
2018
Q3 | $5.6M | Sell |
70,733
-1,083
| -2% | -$81.9K | 0.09% | 91 |
|
|
2018
Q2 | $5.04M | Sell |
71,816
-6,528
| -8% | -$470K | 0.09% | 98 |
|
|
2018
Q1 | $5.48M | Sell |
78,344
-1,284
| -2% | -$88.9K | 0.09% | 96 |
|
|
2017
Q4 | $5.53M | Sell |
79,628
-1,761
| -2% | -$119K | 0.08% | 97 |
|
|
2017
Q3 | $5.51M | Sell |
81,389
-1,600
| -2% | -$101K | 0.08% | 110 |
|
|
2017
Q2 | $5.66M | Sell |
82,989
-1,630
| -2% | -$106K | 0.09% | 112 |
|
|
2017
Q1 | $5.27M | Sell |
84,619
-4,270
| -5% | -$249K | 0.08% | 117 |
|
|
2016
Q4 | $4.86M | Sell |
88,889
-6,242
| -7% | -$354K | 0.07% | 112 |
|
|
2016
Q3 | $6.25M | Sell |
95,131
-421
| -0.4% | -$27.5K | 0.1% | 102 |
|
|
2016
Q2 | $5.77M | Buy |
95,552
+56,936
| +147% | +$3.31M | 0.09% | 101 |
|
|
2016
Q1 | $2.17M | Sell |
38,616
-64,627
| -63% | -$3.88M | 0.04% | 118 |
|
|
2015
Q4 | $7.01M | Sell |
103,243
-72
| -0.1% | -$4.72K | 0.13% | 87 |
|
|
2015
Q3 | $6.58M | Buy |
103,315
+179
| +0.2% | +$11.8K | 0.12% | 84 |
|
|
2015
Q2 | $6.57M | Buy |
103,136
+27,930
| +37% | +$1.91M | 0.11% | 89 |
|
|
2015
Q1 | $5.15M | Sell |
75,206
-2,892
| -4% | -$201K | 0.09% | 99 |
|
|
2014
Q4 | $5.5M | Sell |
78,098
-1,900
| -2% | -$136K | 0.09% | 88 |
|
|
2014
Q3 | $5.71M | Buy |
79,998
+2,573
| +3% | +$188K | 0.09% | 93 |
|
|
2014
Q2 | $5.75M | Sell |
77,425
-10,928
| -12% | -$790K | 0.08% | 95 |
|
|
2014
Q1 | $5.73M | Buy |
88,353
+2,261
| +3% | +$146K | 0.09% | 92 |
|
|
2013
Q4 | $5.11M | Buy |
86,092
+37,260
| +76% | +$2.02M | 0.08% | 91 |
|
|
2013
Q3 | $2.54M | Buy |
48,832
+1,867
| +4% | +$93.8K | 0.04% | 104 |
|
|
2013
Q2 | $2.22M | Buy |
+46,965
| New | +$2.39M | 0.04% | 105 |
|
Other funds holding AZN
EP
IA
Guardian Capital (Canada)'s AZN Position: Q2 2026 in Review
Guardian Capital (Canada) increased its AstraZeneca (AZN) stake by 4.1% in Q2 2026, buying an estimated $1.3M and bringing the position to 177,185 shares worth $33.6M. The position accounts for 0.82% of the portfolio, ranked #36.
Guardian Capital (Canada) first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Guardian Capital (Canada) held 177,185 shares of AstraZeneca worth $33.6M as of Q2 2026.
- Guardian Capital (Canada) bought 6,933 AstraZeneca shares in Q2 2026, an estimated $1.3M.
- AstraZeneca made up 0.82% of Guardian Capital (Canada)'s portfolio in Q2 2026, its #36 holding.
- Guardian Capital (Canada) first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Guardian Capital (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.